Permanent by Design: The Silicone Injections Surgeons Spend Careers Removing

Every reconstructive practice in a large American city has a version of the same patient. She arrives ten or fifteen or twenty five years after an injection she paid cash for in an apartment, a hotel room, or a salon back room. The result was good at first. Then something changed: a hardening, a lump that moved, a patch of skin that would not settle, a swelling that flares and recedes and flares again. She does not know what she was injected with. Nobody wrote it down. The person who injected it is not findable, and in some cases is in prison.

This is the quietest serious problem in aesthetic medicine, and it is almost entirely absent from the consumer conversation, which spends its attention on whether a hyaluronic acid filler lasts nine months or twelve. Liquid silicone and the assorted substances sold under the umbrella term biopolymers are the opposite category. They are permanent, they are unregulated in the settings where they are most often used, and the medical system's answer to them is not a dissolving agent. It is a surgeon with a scalpel and a realistic conversation about how much tissue has to come out with them.

What is actually in the syringe

The short answer: often nobody knows, and that is not a rhetorical flourish. Material recovered from patients has included industrial and automotive grade silicone, mineral oil, petroleum jelly, paraffin, and mixtures nobody has been able to fully characterize.

The term biopolymers, widely used across Latin America and among patients who received injections there, is a marketing word rather than a chemical description. It groups together anything permanent and injectable that was not sold through a regulated pharmaceutical channel. Case series describing removal surgery routinely note that the operative team cannot identify the substance because no product label ever existed and the patient was never told.

Silicone is the most common single culprit. Polydimethylsiloxane exists in a wide range of viscosities and purities, from ophthalmic grade product manufactured under pharmaceutical controls to hardware store sealant. Injectors operating outside medicine have used all of it. The material is cheap, it is easy to obtain, it does not require refrigeration, and it produces an immediate visible result, which is exactly the combination that makes it attractive to someone selling volume by the syringe with no follow up obligation.

The volumes involved separate this from anything that happens in a licensed practice. A conservative facial filler appointment uses one or two milliliters. Buttock injections at a pumping party are measured in hundreds of milliliters, sometimes more than a liter across sessions, delivered through large bore needles into tissue planes nobody imaged first.

Why "medical grade silicone" is not a category

The short answer: the Food and Drug Administration has not approved any injectable silicone for body contouring or large volume augmentation, and it has issued explicit safety warnings against the practice, so a promise of medical grade product is a claim about nothing that regulators recognize.

There is a genuine and narrow legitimate use, and it is worth stating precisely because it is what the marketing borrows from. Two highly purified silicone oil products are approved in the United States as intraocular tamponade agents for retinal detachment surgery. Physicians have used one of them off label in facial microdroplet technique, injecting extremely small quantities in serial sessions for indications such as facial lipoatrophy and depressed acne scarring. That practice is confined to a small number of experienced physicians, involves microliter volumes, and has always been contested within the specialty.

Nothing about that narrow application transfers to a buttock or a hip. The FDA's safety communication on the subject is direct: injectable silicone is not approved for body contouring or enhancement, the agency has received reports of serious injury and death, and the products used are frequently not what they are represented to be. State medical boards and district attorneys have prosecuted these cases as unlicensed practice of medicine, and some have been prosecuted as homicides after patients died.

"

Permanent is sold as a feature. It is the entire problem. Every other decision in aesthetics can be revised, dissolved, or simply waited out. This one cannot, and it does not stay where it was put.

"

It is worth naming the legitimate permanent product for contrast. A polymethylmethacrylate microsphere filler suspended in collagen is FDA approved for specific facial indications and is effectively permanent. Even that product, manufactured, labeled, and injected by physicians in small volumes, carries a revision burden that many injectors consider reason enough to avoid it. That is the ceiling of what regulated permanence looks like. Unlabeled oil injected by the cup is not a more aggressive version of the same thing. It is a different activity.

What the tissue does over the following decade

The short answer: the body cannot metabolize or excrete silicone, so it walls the material off, and the resulting inflammatory response can begin within days or wait twenty years before it announces itself.

The acute risk is the one that kills. Silicone that enters the venous circulation during injection can travel to the lungs, producing acute silicone embolism syndrome: shortness of breath, low oxygen levels, fever, chest pain, and alveolar hemorrhage, sometimes progressing to respiratory failure within hours. It is uncommon relative to the number of injections performed, and it is one of the reasons the volumes and injection planes involved in buttock work are so dangerous.

The chronic picture is what fills clinics. The material migrates, because tissue planes are not sealed compartments and gravity has decades to work. Silicone injected into buttocks is recovered from thighs and lower legs. Facial injections descend. Around the deposits, the immune system forms foreign body granulomas: firm, sometimes tender nodules that can ulcerate through skin, become chronically infected, distort contour, and recur after treatment.

The latency is the part patients find hardest to accept in advance. Granulomatous flares have been documented years and in some series decades after the original injection, sometimes triggered by an unrelated infection, an injury, or a systemic immune event. A result that was stable for fifteen years is not evidence of safety. It is evidence that fifteen years have passed.

The associated syndromes are also real, if less crisply defined: chronic cellulitis in affected regions, lymphedema when lymphatic drainage is obstructed, disfiguring hardening, and a body of literature on systemic inflammatory responses to injected adjuvants that remains contested in its details and consistent in its direction.

Removal is an operation, not a reversal

The short answer: there is no enzyme, solvent, or laser that dissolves injected silicone, so treatment means surgically excising the material along with the tissue it has infiltrated, usually in stages, often with reconstruction.

Hyaluronic acid created a patient expectation that does not generalize. Hyaluronidase breaks down hyaluronic acid within hours because the body already produces an enzyme for that specific molecule. There is no equivalent for silicone, for mineral oil, or for an unidentified biopolymer, and there will not be one, because the material is not biological.

Silicone does not sit in a tidy pocket that can be drained. It disperses through fat and along fascial planes and becomes physically continuous with the tissue it occupies. Removal therefore means resection: taking out the involved tissue itself. In the buttocks and hips that can mean large volume excision with significant contour loss, skin resection, drains, staged operations months apart, and results that a reconstructive surgeon will describe as improvement rather than restoration. Facial cases can require careful dissection near nerves and vessels for material that has migrated far from where it entered.

Where excision is not feasible, management is medical rather than curative: systemic corticosteroids, minocycline, and immunomodulating agents have all been used to quiet granulomatous flares, with the understanding that the material remains and the flares can return.

The cost picture is the final insult. The original injection was chosen because it was inexpensive. The removal is a multi stage reconstructive undertaking that insurance often disputes as cosmetic in origin, performed by a small number of surgeons who have developed specific expertise in it, at a price that dwarfs the legitimate operation the patient could not afford in the first place.

Who this actually happens to

The short answer: this is a problem of price, access, and exclusion, concentrated among patients priced out of licensed surgery and among transgender women who have historically been refused care by the medical system entirely.

The pumping party is the recurring setting: a non clinical space, an unlicensed operator, cash, multiple clients in a session, and industrial silicone sealed at the injection site with cyanoacrylate glue and cotton. Public health investigations and the medical literature have documented this pattern for decades in the United States, with transgender women the most consistently affected group. The reason is not mysterious. When gender affirming care is unavailable, unaffordable, or gatekept out of reach, an underground market fills the gap, and the people in it are unusually reluctant to present to emergency departments when something goes wrong.

The second population is buttock augmentation shoppers facing the gap between a legitimate fat grafting procedure at an accredited facility and an advertised price a fraction of that. The gap is where the illegal market lives. Medical tourism adds a third route, where a patient returns home with a good early result, no operative report, no product documentation, and no relationship with anyone who can explain what was used.

None of these patients are naive in the way the framing usually implies. They are making a rational decision inside a constrained set of options, which is exactly why the useful response is information about permanence and removal rather than a lecture about judgment.

The honest summary

Injected liquid silicone and unlabeled biopolymers are the one decision in aesthetics that cannot be undone, and they are sold specifically on the appeal of never having to decide again.

The regulatory position is not ambiguous. No injectable silicone is approved in the United States for body contouring. The narrow off label facial microdroplet practice that legitimate physicians point to involves microliter volumes and shares nothing with what happens at a pumping party except the chemical family. The phrase medical grade, used to sell body injections, describes no category any regulator recognizes.

The clinical trajectory is well documented and slow. Migration, granuloma formation, chronic infection, lymphedema, and contour destruction can appear at any point from the first week to the third decade, and stability so far predicts nothing about stability ahead.

The remedy is surgical and partial. There is no dissolving agent, and there is no reason to expect one. Excision means removing tissue, in stages, at a cost far above the legitimate procedure the patient originally declined.

If you are considering an injectable of any kind, the single question that protects you is the one about the label: product name, manufacturer, lot number, recorded in your chart. Regulated medicine can answer it in five seconds. Nothing else can answer it at all. And if you already have silicone in your body from an injection nobody documented, the right move is a consultation with a board certified plastic surgeon who treats these cases specifically, sooner rather than after the next flare, because the operation is easier before the tissue has been inflamed for another decade.